Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

11.11USD
17 Jan 2019
Change (% chg)

$-0.40 (-3.48%)
Prev Close
$11.51
Open
$11.46
Day's High
$11.77
Day's Low
$11.08
Volume
162,422
Avg. Vol
237,097
52-wk High
$20.65
52-wk Low
$8.34

Select another date:

Thu, Nov 8 2018

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount

Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.

Coherus prices biosimilar to Amgen's Neulasta at 33 pct discount

Nov 8 Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.

Select another date: